Kaitlin N Piper1, Cam Escoffery1, Jessica M Sales1, Anandi N Sheth2. 1. Rollins School of Public Health, Emory University, Atlanta, Georgia. 2. Division of Infectious Diseases, Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia. Electronic address: ansheth@emory.edu.
Abstract
PURPOSE: HIV pre-exposure prophylaxis (PrEP) is underutilized by adolescent and young adult women, especially in the Southern U.S. Family planning (FP) clinics are potentially ideal PrEP delivery sites for adolescent and young adult women, but little is known about their PrEP services. We describe models of PrEP care in Title X FP clinics in the South and explore clinic resources that are needed to facilitate PrEP provision. METHODS: Providers and administrators from 38 clinics participated in qualitative interviews. We assessed five steps of PrEP care: (1) HIV risk assessment; (2) PrEP education; (3) laboratory testing; (4) PrEP prescription; and (5) PrEP monitoring. RESULTS: Among 38 clinics, 23 conducted at least one step and were classified into three models. Model 1 (n = 8) and Model 2 (n = 4) clinics provided up to Steps 1 and 2, respectively, but referred to an external PrEP provider. Model 3 clinics (n = 11) conducted all steps. Few barriers were identified for Step 1; using an HIV risk assessment tool was a key facilitator. PrEP educational materials facilitated Step 2; clinics not providing education believed they could easily do so with training and educational resources. Funding- and staff-related resource barriers were noted for Steps 3-5, including costs of laboratory tests and lack of time for longitudinal visits. CONCLUSIONS: PrEP-providing publicly funded FP clinics in the Southern U.S. use referral services for many steps of PrEP care, which introduce patient burden. Increasing onsite PrEP services will require addressing concerns related to training, educational materials, cost, and staffing.
PURPOSE: HIV pre-exposure prophylaxis (PrEP) is underutilized by adolescent and young adult women, especially in the Southern U.S. Family planning (FP) clinics are potentially ideal PrEP delivery sites for adolescent and young adult women, but little is known about their PrEP services. We describe models of PrEP care in Title X FP clinics in the South and explore clinic resources that are needed to facilitate PrEP provision. METHODS: Providers and administrators from 38 clinics participated in qualitative interviews. We assessed five steps of PrEP care: (1) HIV risk assessment; (2) PrEP education; (3) laboratory testing; (4) PrEP prescription; and (5) PrEP monitoring. RESULTS: Among 38 clinics, 23 conducted at least one step and were classified into three models. Model 1 (n = 8) and Model 2 (n = 4) clinics provided up to Steps 1 and 2, respectively, but referred to an external PrEP provider. Model 3 clinics (n = 11) conducted all steps. Few barriers were identified for Step 1; using an HIV risk assessment tool was a key facilitator. PrEP educational materials facilitated Step 2; clinics not providing education believed they could easily do so with training and educational resources. Funding- and staff-related resource barriers were noted for Steps 3-5, including costs of laboratory tests and lack of time for longitudinal visits. CONCLUSIONS: PrEP-providing publicly funded FP clinics in the Southern U.S. use referral services for many steps of PrEP care, which introduce patient burden. Increasing onsite PrEP services will require addressing concerns related to training, educational materials, cost, and staffing.
Authors: Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden Journal: Lancet Infect Dis Date: 2014-07-22 Impact factor: 25.071
Authors: Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan Journal: Ann Epidemiol Date: 2018-06-15 Impact factor: 3.797
Authors: Anar S Patel; Lakshmi Goparaju; Jessica M Sales; Cyra Christina Mehta; Oni J Blackstock; Dominika Seidman; Igho Ofotokun; Mirjam-Colette Kempf; Margaret A Fischl; Elizabeth T Golub; Adaora A Adimora; Audrey L French; Jack DeHovitz; Gina Wingood; Seble Kassaye; Anandi N Sheth Journal: J Acquir Immune Defic Syndr Date: 2019-04-15 Impact factor: 3.731
Authors: Sarah K Calabrese; Douglas S Krakower; Tiara C Willie; Trace S Kershaw; Kenneth H Mayer Journal: Clin Infect Dis Date: 2019-08-16 Impact factor: 9.079
Authors: Aaron J Siegler; Kenneth H Mayer; Albert Y Liu; Rupa R Patel; Lauren M Ahlschlager; Colleen S Kraft; Rossi Fish; Sarah E Wiatrek; Patrick S Sullivan Journal: Clin Infect Dis Date: 2019-01-18 Impact factor: 9.079
Authors: Jessica M Sales; Cam Escoffery; Sophia A Hussen; Lisa B Haddad; Ashley Phillips; Teresa Filipowicz; Maria Sanchez; Micah McCumber; Betty Rupp; Evan Kwiatkowski; Matthew A Psioda; Anandi N Sheth Journal: JMIR Res Protoc Date: 2019-05-06
Authors: Caroline G Coleman; Jessica M Sales; Cam Escoffery; Kaitlin N Piper; Leah Powell; Anandi N Sheth Journal: J Gen Intern Med Date: 2021-01-14 Impact factor: 6.473